Study shows that Probi probiotics may delay the onset of gluten intolerance in children

74f53ea4-6a0a-4f3a-aac1-1ec8215749d2articleimage.jpg

11 Sep 2017 --- A clinical trial evaluating the effect of probiotics from Probi in children genetically predisposed for gluten intolerance has shown that these probiotics have a suppressing effect on celiac autoimmunity and may delay the onset of the disease. Celiac disease affects up to 3 percent of the population, and currently, the introduction of a lifelong gluten-free diet is the only available treatment.

The randomized, double-blind, placebo controlled intervention study was performed by Dr. Daniel Agardh and his research team at Lund University with the objective of evaluating the effect of Probi’s probiotic strains Lactobacillus plantarum Heal 9 and Lactobacillus paracasei 8700:2 on Celiac Disease (CD) autoimmunity. Seventy-eight asymptomatic children (3-7 years old) with an increased risk for developing CD were randomly allocated to a daily consumption of either the probiotic product or a placebo for a total period of 6 months while on a gluten-containing diet. The 78 children were identified as a subpopulation in a multinational and multiyear autoimmunity study with thousands of children.

The study results show that the levels of the disease-related antibodies were significantly reduced in the probiotic group and significantly increased in the placebo group during the course of the study. In addition, several significant differences were observed between the groups on a cellular level indicating that the probiotic may counteract CD-associated ongoing immunological and inflammatory response.

“To our knowledge, this is the first time a probiotic study has been performed on this specific population and the results show immune-supporting properties of these probiotics as well as a potential preventive effect on the development of CD,” says Daniel Agardh.

“This is an excellent example of a well-working collaboration between academia and the industry” says Peter Nählstedt, CEO of Probi AB. “We see a growing interest in children’s probiotics and these results enable Probi to build a product platform for children.”

“The probiotic was administered in a sachet, and the subjects were instructed to sprinkle the powder on their food or dissolve it in water. Probi has recently launched a new fast melting powder formulation which would be a suitable format for a commercial product,” Nählstedt tells NutritionInsight

“This was a study in a population that has, to our knowledge, not been studied before. We are very excited about the good results and based on the evaluation of the data we will now build our product platform for children. For companies that are interested in marketing a product with the strains, Probi is able to formulate a fast melting powder or other desired product format,” Nählstedt adds.

Probi’s proprietary probiotic strains Lactobacillus plantarum Heal 9 and Lactobacillus paracasei 8700:2 are patent protected, of human origin and are commercially available. The results of the study were presented at the International Celiac Disease Symposium in New Delhi, India, on 10 September.

By Lucy Gunn

Related Articles

Nutrition & Health News

Clear definition and regulations needed to tap into nutraceuticals’ potential: review

13 Feb 2018 --- Nutraceuticals with health benefits substantiated by clinical data can be powerful tools to prevent and treat medical conditions, especially in individuals who may not yet be eligible for conventional pharmaceutical drugs. However, there is a clear need for clear regulations to ensure their safety. This is according to a review published in the British Journal of Clinical Pharmacology, which further proposes a clear definition for this type of product. 

Nutrition & Health News

Immunity boosters (Part 2): Not diplomatic about immunity – Innovation, new ingredients and R&D

12 Feb 2018 --- Immune health continues to drive trends in the nutrition industry. Today, in the second part of a special report, NutritionInsight continues its in-depth look at the latest ideas in the industry in the immune health space.

Nutrition & Health News

Gluten-free check: new technique improves gluten detection

08 Feb 2018 --- The number of gluten-free food options in the stores has been growing steadily over the past years; a development largely pushed forward by consumer demand for foods that consumers believe “work for me,” whether this is based on science or otherwise. However, current tests for gluten are not finding all of the substance in foods, resulting in some products being labeled “gluten-free” when they really aren't. This mislabeling can cause serious health consequences for those with celiac disease and gluten-sensitivities. Now researchers Kevin D. Dorfman, Scott P. White and C. Daniel Frisbie report that they have developed a fast gluten detector that has the potential to detect and quantify different sources of gluten than those currently on the market.

Nutrition & Health News

Probi’s largest clinical trial confirms the immune enhancing impact of Defendum probiotic

07 Feb 2018 --- Probi's largest clinical trial ever, focused on probiotic immune health, has confirmed a strong clinical immune enhancing effect of Probi Defendum. According to the company, the study proves that Probi Defendum helps protect against recurrent colds and sheds some light on the mechanism of action behind the effect.

Nutrition & Health News

Infant nutrition market becomes a bit more wholesome with gut-friendly organic yogurt launch

01 Feb 2018 --- Premium organic baby food brand Happy Family has launched what it says is the first-ever organic yogurt line with no added sweeteners for babies and toddlers. Designed for infants starting at six months and up to three years old, the Happy Baby and Happy Tot Whole Milk Yogurt line is made with whole milk, vitamin D and probiotics. 

More Articles
URL : http://www.nutritioninsight.com:80/news/study-shows-that-probi-probiotics-may-delay-the-onset-of-gluten-intolerance-in-children.html